Home
>
National Drug Code (NDC)
>
BioThrax
BioThrax - 64678-211-01 - (BACILLUS ANTHRACIS)
Drug Information of BioThrax
| Product NDC: | 64678-211 |
| Proprietary Name: | BioThrax |
| Non Proprietary Name: | BACILLUS ANTHRACIS |
| Active Ingredient(s): | 100 ug/mL & nbsp; BACILLUS ANTHRACIS |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BioThrax
| Product NDC: | 64678-211 |
| Labeler Name: | Emergent BioDefense Operations Lansing, LLC |
| Product Type: | VACCINE |
| FDA Application Number: | BLA103821 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19701104 |
Package Information of BioThrax
| Package NDC: | 64678-211-01 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (64678-211-01) > 5 mL in 1 VIAL, MULTI-DOSE (64678-211-05) |
NDC Information of BioThrax
| NDC Code | 64678-211-01 |
| Proprietary Name | BioThrax |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (64678-211-01) > 5 mL in 1 VIAL, MULTI-DOSE (64678-211-05) |
| Product NDC | 64678-211 |
| Product Type Name | VACCINE |
| Non Proprietary Name | BACILLUS ANTHRACIS |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19701104 |
| Marketing Category Name | BLA |
| Labeler Name | Emergent BioDefense Operations Lansing, LLC |
| Substance Name | BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS |
| Strength Number | 100 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Live Attenuated Bacillus Anthracis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Anthrax Vaccines [Chemical/Ingredient] |
